DPP-1 Inhibitors Aim to Reduce Bronchiectasis Flare-Ups
A new class of drugs offers a disease-based approach to managing non-cystic fibrosis bronchiectasis by targeting airway inflammation.
A new class of drugs offers a disease-based approach to managing non-cystic fibrosis bronchiectasis by targeting airway inflammation.
Mechanical ventilation is one of the most common ICU interventions, and understanding and accurately interpreting ventilator graphics may reduce risks and improve patient outcomes.
Remote monitoring did not increase the time spent at home after discharge among patients hospitalized with sepsis or lower respiratory tract infection, according to results from a randomized clinical trial of 1,286 adults.
ENA Respiratory received notices of allowance for two US patents covering its innate immune modulators and their application in preventing COPD exacerbations.